NYSE-Listed Dr. Reddy’s to Buy German Medical Cannabis Company Nimbus Health

New Cannabis Ventures
By NCV NewswireFeb 3, 2022, 7:46 pm448 pts
Dr. Reddy’s Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH FRANKFURT, Germany & HYDERABAD, India, February 03, 2022–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Collective Project Launches Portfolio of Hemp-Derived THC Beverages in 25 States 69

Oregon Police Improperly Used Aerial Camera To Bust Marijuana Grow, State Appeals Court Says 69

DEA Provides No Cannabis Rescheduling Update After 180 Days 69

Nature’s Heritage Brings Old-School Genetics to the Modern Market 68

4 Pitfalls to Avoid When Seeking a Cannabis Trademark (and Tips to Avoid Them) 68

Built to Withstand: 5 Adaptations Cannabis Facilities Should Make for Corrosion Resistance 62

FLUENT Opens Company’s 1st Adult-Use Dispensary in New York 27

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.